Advertisement

Subcellular localization of α-synuclein in primary neuronal cultures: effect of missense mutations

  • P. J. McLean
  • S. Ribich
  • B. T. Hyman
Conference paper

Summary

Numerous recent observations have implicated α-synuclein in the pathogenesis of several neurodegenerative diseases, including Parkinson’s disease, Alzheimer’s disease, dementia with Lewy bodies and multiple-system atrophy. Two missense mutations in the gene for α-synuclein have been identified in some cases of familial Parkinson’s disease and it is thought that these may disrupt the normal structure of the protein and thus promote aggregation into Lewy body filaments. Here, we examine the subcellular localization of α-synuclein in primary cortical neurons maintained in a monolayer culture. The protein has widespread expression throughout neurons, including the nucleus, and has a discete localization in the neurites of more mature neurons, reminiscent of synaptic specializations. Interestingly, in a subpopulation of cortical neurons transfected at 13 days in vitro, we find that α-synuclein appears to aggregate into distinct punctate inclusions in the cytoplasm and proximal neurites. Unlike Lewy bodies, these structures are not ubiquitin positive. These regions of α-synuclein accumulation are observed following transfections with wild-type, Ala30Pro or Ala53Thr α-synuclein; neither mutation alters their frequency.

Keywords

Lewy Body Expression Construct Primary Cortical Neuron Discrete Localization Primary Neuronal Culture 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Davidson W.S., Jonas A, Clayton D.F., George J.M. (1998) Stabilization of α-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem 273: 9443–9449PubMedCrossRefGoogle Scholar
  2. Engelender S, Guo X, Hoffman B.E. (1998) Synphilin-1: a novel protein that interacts with alpha-synuclein. Soc Neurosci Abstr 24 (Part 1): 968Google Scholar
  3. George J.M., Jin H, Woods W.S., Clayton D.F. (1995) Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 15:361–372PubMedCrossRefGoogle Scholar
  4. Irizarry M.C., Kim T-W, McNamara M, Tanzi R.E., George J.M., Clayton D.F., Hyman B.T. (1996) Characterization of the precursor protein of the non-Ab component of senile plaques (NACP) in the human central nervous system. J Neuropathol Exp Neurol 55:889–895Google Scholar
  5. Irizarry M.C., Growdon W, Gomez-Isla T, Newell K, George J.M., Clayton D.F., Hyman B.T. (1998) Nigral and corticallewy bodies and dystrophic nigral neurites in Parkinson’s disease and cortical lewy body disease contain α-synuclein immunoreactivity. J Neuropathol Exp Neurol 57: 334–337PubMedCrossRefGoogle Scholar
  6. Iwai A, Masliah E, Yoshimoto M, Ge N, Flanagan L, Silva HARd, Kittel A, Saitoh T (1995) The precursor protein of non-Aβ component of Alzheimer’s disease amyloid is a presynaptic protein of the central nervous system. Neuron 14: 467–475PubMedCrossRefGoogle Scholar
  7. Jakes R, Spillantini M.G., Goedert M (1994) Identification of two distinct synucleins from human brain. FEBS Lett 345: 27–32Google Scholar
  8. Jensen P.H., Nielsen M.S., Jakes R, Dotti C.G., Goedert M (1998) Binding of α-synuclein to brain vesicles is abolished by familial Parkinson’s disease mutation. J Biol Chem 273:26292–26294PubMedCrossRefGoogle Scholar
  9. Johnston J.J., Ward C.L., Kopito R.R. (1998) Aggresomes: a cellular response to misfolded proteins. J Cell Biol 143: 1883–1898PubMedCrossRefGoogle Scholar
  10. Krüger R, Kuhn W, Müller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen J.T., Schols L, Riess O (1998) Ala30Pro mutation in the gene encoding α-synuclein in Parkinson’s disease. Nat Genet 18: 106–108PubMedCrossRefGoogle Scholar
  11. Maroteaux L, Campanelli J.T., Scheller R.H. (1988) Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci 8: 2804–2815PubMedGoogle Scholar
  12. Nakajo S, Kawarazaki S, Kanai T, Hirabayashi T, Nakaya K (1998) Analysis of binding proteins for PNP-14 and α-synuclein. Soc N eurosci Abstr 24 (Part 1): 967Google Scholar
  13. Payton J.E., Perrin R.J., Clayton D.F., George J.M. (1998) Protein-protein interactions of asynuclein. Soc Neurosci Abstr 24 (Part 1): 966Google Scholar
  14. Polymeropoulos M.H., Lavedan C, Leroy E, Idle S.E., Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos E.S., Chandrasekharappa S, Athanassiadou A, Papaetropoulos T, Johnson W.G., Lazzarini A.M., Duvoisin R.C., Iorio G.D., Golbe L.I., Nussbaum R.L. (1997) Mutation in the α-Synuclein gene identified in families with Parkinson’s disease. Science 276: 2045–2047PubMedCrossRefGoogle Scholar
  15. Spillantini M.G., Schmidt M.L., Lee M-Y, Trowjanowski J.Q., Jakes R, Goedert M (1997) α-Synuclein in Lewy bodies. Nature 388: 839–840PubMedCrossRefGoogle Scholar
  16. Xia Z, Dudek H, Miranti C.K., Greenberg M.E. (1996) Calcium influx via the NMDA receptor induces immediate early gene transcription by a MAP kinase/ERK-dependent mechanism. J Neurosci 16: 5425–5436PubMedGoogle Scholar

Copyright information

© Springer-Verlag Wien 2000

Authors and Affiliations

  • P. J. McLean
    • 1
  • S. Ribich
    • 1
  • B. T. Hyman
    • 1
  1. 1.Neurology Service, Alzheimer Research UnitMassachusetts General Hospital-EastCharlestownUSA

Personalised recommendations